Pharmaceutical Industry
India  /  Published 13.05.20

Pharma faces swadeshi challenge

India’s pharmaceutical industry imports over 70 per cent of key chemical ingredients and will find it challenging to heed Prime Minister Narendra Modi’s call on Tuesday for self-reliance across se...
By G.S. Mudur in New Delhi

Education  /  Published 28.04.20

Pharma future

The coronavirus pandemic has hit us hard, socially, financially and emotionally. By now, we are familiar with the need to flatten the curve by practicing social distancing. But what will happen after ...
By Ishani Banerji in

Business  /  Published 12.04.20

Covid-19 lockdown: Start plan for 5 sectors

The government has sought inputs related to production, labour and logistics from clusters in five key sectors to ascertain expected output if they are made operational within a fortnight and procedur...
By PTI in New Delhi

Business  /  Published 20.03.20

Vaccine fillip for pharma

Shares of pharmaceutical companies that make anti-malarial drugs gained on Friday after US President Donald Trump said chloroquine, a drug used to treat malaria, has been approved by the US Food and D...
By Our Special Correspondent in Mumbai

Business  /  Published 18.02.20

Coronavirus spooks pharmaceutical sector

The prices of key pharmaceutical ingredients could rise if the coronavirus situation in China does not improve soon, a top company official said on Tuesday. “The prices of active pharmaceutical ing...
By PTI in New Delhi

India  /  Published 28.01.20

Pharma industry likely to grow at 10-13 pc

The growth trajectory for the Indian pharmaceutical industry is likely to remain at 10-13 per cent in 2020-21 despite challenges, according to rating agency Icra.The expected growth in the next financ...
By PTI in New Delhi

India  /  Published 19.05.19

Free chest X-ray vouchers push up TB diagnosis: Study

Health researchers have shown that private pharmacists in India can help find tuberculosis patients and direct them for diagnosis and appropriate treatment and curb treatment delays that threaten Indi...
By G.S. Mudur in New Delhi

Opinion  /  Published 09.07.19

TB threat requires interdisciplinary response

It’s been a few years but I clearly remember a visit to a chest ward in a hospital in Patna. Tuberculosis patients, their faces emaciated, lay on their beds, staring, coughing, in despair. These imp...
By Shaibal Gupta in

Business  /  Published 14.05.19

Pharmaceutical duo vow to fight price fix charge

Drug majors Aurobindo Pharma and Dr Reddy’s Laboratories on Tuesday said they were preparing their legal defence to the charges of price fixing in the US market.As many as 49 US states have filed pr...
By Our Special Correspondent in Mumbai

Business  /  Published 07.04.19

Lupin recalls birth control pills

By PTI in New Delhi


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.